LUCENTIS vs SUSVIMO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Attribute	LUCENTIS	SUSVIMO
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	RANIBIZUMAB	RANIBIZUMAB
Manufacturer	Genentech Inc	Genentech Inc
Dosage forms	Injectable	Injectable
Drug class	Vascular Endothelial Growth Factor Inhibitor	Vascular Endothelial Growth Factor Inhibitor
Boxed warning	None	Boxed warning
Treats	Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion	Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion

lucentis susvimo

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

RANIBIZUMAB

Manufacturer

Genentech Inc

Dosage forms

Injectable

Drug class

Vascular Endothelial Growth Factor Inhibitor

Boxed warning

None

Boxed warning

Treats

Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion

Frequently asked questions

Which is better-rated, Lucentis or Susvimo?

Lucentis and Susvimo are tied at 3.5 out of 5 by our independent rating.

What is the difference between Lucentis and Susvimo?

Both Lucentis and Susvimo share the active ingredient Ranibizumab.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.